ClassID:

112011

C12N2795/10222 - CPC Classification

Classification description:

Bacteriophages; Details dsDNA Bacteriophages; Podoviridae New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Recent Application in this class:
#1
20250185668
2025-06-12

BACTERIOPHAGE, BACTERIAL WILT DISEASE CONTROL AGENT, AND BACTERIAL WILT DISEASE CONTROL METHOD

#2
20240366694
2024-11-07

PHAGE THERAPY OF E COLI INFECTIONS

#3
20240082420
2024-03-14

DELIVERY OF THERAPEUTIC RNAS VIA ARRDC1-MEDIATED MICROVESICLES

#4
20240024391
2024-01-25

Antibacterial composition and uses thereof

#5
20230310525
2023-10-05

BACTERIOPHAGE VARIANTS HAVING EXTENDED HOST-RANGE, METHODS FOR PREPARATION AND USES THEREOF IN TRANSDUCING NUCLEIC ACIDS INTO HOSTS OF INTEREST

#6
20220192213
2022-06-23

CROP TREATMENT

#7
20220162568
2022-05-26

PORE

#8
20210213139
2021-07-15

Delivery of therapeutic RNAs via ARRDC1-mediated microvesicles

#9
20210087538
2021-03-25

Compositions of and methods for in vitro viral genome engineering

#10
20210060100
2021-03-04

Phage therapy of infections

#11
20210009963
2021-01-14

Oncolytic T7 bacteriophage having cytokine gene and displaying homing peptide on capsid and its use for treating melanoma

#12
20200030392
2020-01-30

Anti-bacterial compositions and uses thereof

#13
20190322988
2019-10-24

Compositions of and methods for in vitro viral genome engineering

#14
20190321422
2019-10-24

Bacteriophage variants having extended host-range, methods for preparation and uses thereof in transducing nucleic acids into hosts of interest

#15
20190211312
2019-07-11

Compositions of and methods for in vitro viral genome engineering

#16
20190085031
2019-03-21

PROTEIN VARIANTS FOR USE AS LIPID BILAYER-INTEGRATED NANOPORE, AND METHODS THEREOF

#17
20190017990
2019-01-17

Proteoliposome and production method thereof

#18
20190002840
2019-01-03

Phage therapy of infections

#19
20180371494
2018-12-27

T7 alpha viral vector system

#20
20180282737
2018-10-04

Uncoupling growth and protein production

#21
20180282703
2018-10-04

Bacteriophage and antibacterial composition comprising the same

#22
20180016299
2018-01-18

METHODS FOR MAKING ARRAYS FOR HIGH THROUGHPUT PROTEOMICS

#23
20170362282
2017-12-21

Engineered programmable molecular scaffolds from porous protein crystals

#24
20170190798
2017-07-06

Proteoliposome and production method thereof

#25
20170000831
2017-01-05

Phage therapy of infections

#26
20160264941
2016-09-15

Phage therapy of pseudomonas infections

#27
20160244745
2016-08-25

Protein scaffolds and methods of use

#28
20160186147
2016-06-30

Compositions of and methods for in vitro viral genome engineering

#29
20160083695
2016-03-24

Bacteriophage and antibacterial composition comprising the same

#30
20150328322
2015-11-19

DRUG DELIVERY VEHICLES

#31
20140295528
2014-10-02

Polypeptides and bacteriophages specific to capsular type strains

#32
20120040890
2012-02-16

Inhibitor of the uracil-DNA glycosylase enzyme and uses thereof

#33
20110143997
2011-06-16

PHAGE RECEPTOR BINDING PROTEINS FOR ANTIBACTERIAL THERAPY AND OTHER NOVEL USES

#34
20100203180
2010-08-12

Antimicrobial protein derived from Podoviridae bacteriophage specific to

#35
20100120675
2010-05-13

INHIBITOR OF THE URACIL-DNA GLYCOSYLASE ENZYME AND USES THEREOF

#36
20100047895
2010-02-25

Methods for purification of bacterial cells and cell components

#37
20090113562
2009-04-30

T7 phage peptide display system and uses thereof

#38
20080318838
2008-12-25

PEPTIDES

#39
20080260763
2008-10-23

High Throughput Proteomics

#40
20060154867
2006-07-13

Compounds for targeting hepatocytes

#41
20050009147
2005-01-13

Peptides